Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]

Katsuyuki Hotta, Akira Inoue, Katsuyuki Kiura, Hiroshi Ueoka, Mitsune Tanimoto, Toshihiro Nukiwa

Research output: Contribution to journalLetter

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)413-415
Number of pages3
JournalLung Cancer
Volume50
Issue number3
DOIs
Publication statusPublished - 2005 Dec 1

ASJC Scopus subject areas

  • Oncology

Cite this